Span K (Potassium Chloride) Dosing Information
I cannot provide dosing recommendations for "Span K tablets" as none of the provided evidence addresses potassium chloride supplementation dosing. The evidence exclusively covers unrelated medications including NSAIDs (diclofenac, meloxicam, ibuprofen, ketorolac), antiarrhythmics, diabetes medications, antihypertensives, and influenza antivirals.
Critical Clarification Needed
If you are asking about diclofenac (an NSAID sometimes confused with "Span K"), the evidence does not contain specific FDA labeling or guideline dosing for diclofenac tablets, though it is mentioned in the context of hepatotoxicity risk 1.
What the Evidence Does Show About NSAIDs (If Relevant)
If you intended to ask about NSAID dosing generally:
Meloxicam Dosing
- Standard dose: 7.5 mg once daily, maximum 15 mg once daily 2
- Duration limit: Should not exceed 2-4 weeks without reassessment due to increased gastrointestinal, cardiovascular, and renal complications 2
- Elderly patients: Maximum 7.5 mg daily 2
Critical Safety Considerations for Any NSAID
- Avoid in patients with eGFR <30 mL/min/1.73 m² 2
- Temporarily suspend during intercurrent illness, IV contrast administration, or before major surgery 2
- Monitor renal function if treatment extends beyond 2 weeks, particularly in elderly or renally impaired patients 2
- Consider gastroprotection with proton pump inhibitors for treatment beyond 2 weeks 2
High-Risk Populations Requiring Dose Adjustment or Avoidance
- Age >60 years increases gastrointestinal bleeding risk from 1 in 2,100 to 1 in 110 2
- Concurrent anticoagulant use increases bleeding risk 5-6 fold 2
- Renal impairment, heart failure, liver disease, and concurrent antihypertensive therapy increase risk of NSAID-induced renal complications 3
Please clarify the specific medication name or provide the active ingredient to receive accurate dosing guidance.